These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 16938516

  • 1. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
    Shimada S, Ishizawa T, Ishizawa K, Matsumura T, Hasegawa T, Hirose T.
    Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516
    [Abstract] [Full Text] [Related]

  • 2. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
    Sirvent N, Coindre JM, Maire G, Hostein I, Keslair F, Guillou L, Ranchere-Vince D, Terrier P, Pedeutour F.
    Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
    [Abstract] [Full Text] [Related]

  • 3. High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma.
    Lee SE, Kim YJ, Kwon MJ, Choi DI, Lee J, Cho J, Seo SW, Kim SJ, Shin YK, Choi YL.
    Histol Histopathol; 2014 Jan; 29(1):127-38. PubMed ID: 23852861
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
    Thway K, Flora R, Shah C, Olmos D, Fisher C.
    Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
    [Abstract] [Full Text] [Related]

  • 5. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
    Kimura H, Dobashi Y, Nojima T, Nakamura H, Yamamoto N, Tsuchiya H, Ikeda H, Sawada-Kitamura S, Oyama T, Ooi A.
    Int J Clin Exp Pathol; 2013 Mar; 6(7):1306-16. PubMed ID: 23826411
    [Abstract] [Full Text] [Related]

  • 6. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
    Creytens D, van Gorp J, Ferdinande L, Speel EJ, Libbrecht L.
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas.
    Hostein I, Pelmus M, Aurias A, Pedeutour F, Mathoulin-Pélissier S, Coindre JM.
    J Pathol; 2004 Jan; 202(1):95-102. PubMed ID: 14694526
    [Abstract] [Full Text] [Related]

  • 8. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
    Kammerer-Jacquet SF, Thierry S, Cabillic F, Lannes M, Burtin F, Henno S, Dugay F, Bouzillé G, Rioux-Leclercq N, Belaud-Rotureau MA, Stock N.
    Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
    [Abstract] [Full Text] [Related]

  • 9. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.
    Lyle PL, Bridge JA, Simpson JF, Cates JM, Sanders ME.
    Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423
    [Abstract] [Full Text] [Related]

  • 10. Amplification of FRS2 in atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma: a clinicopathological and genetic study of 146 cases.
    Jing W, Lan T, Chen H, Zhang Z, Chen M, Peng R, He X, Zhang H.
    Histopathology; 2018 Jun; 72(7):1145-1155. PubMed ID: 29368794
    [Abstract] [Full Text] [Related]

  • 11. p16 Expression in Fat Necrosis: A Potential Diagnostic Pitfall in the Evaluation of Differentiated Adipocytic Neoplasms.
    Ng W, Messiou C, Smith M, Thway K.
    Int J Surg Pathol; 2015 Oct; 23(7):544-8. PubMed ID: 26173427
    [Abstract] [Full Text] [Related]

  • 12. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma With Features Mimicking Spindle Cell Lipoma.
    Jebastin JAS, Perry KD, Chitale DA, Mott MP, Sanchez J, Fritchie KJ, Palanisamy N, Williamson SR.
    Int J Surg Pathol; 2020 May; 28(3):336-340. PubMed ID: 31672072
    [Abstract] [Full Text] [Related]

  • 13. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
    Chung L, Lau SK, Jiang Z, Loera S, Bedel V, Ji J, Weiss LM, Chu PG.
    Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data.
    Jing W, Lan T, Qiu Y, Peng R, Lu Y, Chen H, Chen M, He X, Chen C, Zhang H.
    Diagn Pathol; 2021 Oct 25; 16(1):96. PubMed ID: 34696768
    [Abstract] [Full Text] [Related]

  • 17. MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors?: A New Perspective.
    Clay MR, Martinez AP, Weiss SW, Edgar MA.
    Am J Surg Pathol; 2016 Dec 25; 40(12):1647-1652. PubMed ID: 27508976
    [Abstract] [Full Text] [Related]

  • 18. Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor.
    Kashima T, Halai D, Ye H, Hing SN, Delaney D, Pollock R, O'Donnell P, Tirabosco R, Flanagan AM.
    Mod Pathol; 2012 Oct 25; 25(10):1384-96. PubMed ID: 22699518
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
    Coindre JM, Hostein I, Maire G, Derré J, Guillou L, Leroux A, Ghnassia JP, Collin F, Pedeutour F, Aurias A.
    J Pathol; 2004 Jul 25; 203(3):822-30. PubMed ID: 15221942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.